Peptide record

TPDB09489

Antibacterial Anticancer Toxicity standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09489
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia
standard
No
A 20-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GYNYAKKLANLAKKFANALW
Physicochemical Analysis
C109H166N28O26
RDCEQHIMPSTV
A
2284.69
10.41
4
0
12
+4
-2.16
-0.340
83.50
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
8480
371.17
5
Residue Composition
number
5
A
0
R
3
N
0
D
0
C
0
E
0
Q
1
G
0
H
0
I
3
L
4
K
0
M
1
F
0
P
0
S
0
T
1
W
2
Y
0
V
Amino Acid Distribution
A: 5 R: 0 N: 3 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 0 L: 3 K: 4 M: 0 F: 1 P: 0 S: 0 T: 0 W: 1 Y: 2 V: 0
Chemical Descriptors
20
C109H166N28O26
2284.69
10.41
+4
-2.16
-0.340
Evidence Records 3 records
Evidence 1 Activity

Activity

<5% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
<5% Hemolysis | 128 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp. | Int J Antimicrob Agents | 2008
Evidence 2 Activity

Activity

50% Cell death
Toxicity
243 µM
Cytotoxic
50% Cell death | 243 | µM | target cell: Mouse fibroblasts NIH 3T3

Target

Mouse fibroblasts NIH 3T3

Source & Reference

NA
DBAASP
Antimicrobial peptide GW-H1-induced apoptosis of human gastric cancer AGS cell line is enhanced by suppression of autophagy. | Mol Cell Biochem | 2015
Evidence 3 Activity

Activity

MHC
Toxicity
128 µM
Hemolytic
Hemolytic_activity: [Ref.18586467] MHC=128 µM against human red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Int J Antimicrob Agents. 2008 Aug 32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.